Fluidigm Corp at Morgan Stanley Healthcare Conference Transcript
We have Chris Linthwaite, CEO of Fluidigm, on stage with me today. Vikram Jog, CFO, and Agnes Lee, VP of Investor Relations in the audience.
Before we get started, I just wanted to remind everyone that all disclosures pertaining to this conversation can be found on our disclosure website at www.morganstanley.com\researchdisclosures.
So Chris, very happy to have you here today. I have a series of questions prepared for you, but I think it'd be a good idea to start off with a high-level overview of your company for some of the investors in the room who might not be as familiar.
Thank you, again. [Edmund], thank you very much for the invitation and for my extension Morgan Stanley for including Fluidigm in the Healthcare Conference.
I think Fluidigm is a company that's really, really interesting for a number of reasons. First, it's a company that's attacking a $3 billion market, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |